Our interest is on the pathobiochemistry of genetic neurometabolic diseases. We are applying an integrated approach based on clinical, biochemical, molecular genetic, magnetic resonance spectroscopy (MRS), and imaging analyses to study and to understand the disease groups . Our mission is to provide the best possible care for children with metabolic diseases and to pursue advances in research, which will improve the quality of life or cure people with Inborn Error of Metabolism.